Mostrar el registro sencillo del ítem

dc.contributor.authorSalamanca, David Ricardospa
dc.contributor.authorMolina Franky, Jessica Stephaniespa
dc.contributor.authorCamargo Mancipe, Anny Jinethspa
dc.contributor.authorGómez Rodríguez, Alida Marcelaspa
dc.date.accessioned2020-03-25 00:00:00
dc.date.accessioned2022-03-08T16:18:49Z
dc.date.available2020-03-25 00:00:00
dc.date.available2022-03-08T16:18:49Z
dc.date.issued2020-03-25
dc.identifier.issn2389-7325
dc.identifier.urihttps://repositorio.uniboyaca.edu.co/handle/uniboyaca/370
dc.format.mimetypeapplication/pdfspa
dc.language.isospaspa
dc.publisherUniversidad de Boyacáspa
dc.rightsRevista Investigación en Salud Universidad de Boyacá - 2020spa
dc.rights.urihttp://creativecommons.org/licenses/by-nc/4.0spa
dc.sourcehttps://revistasdigitales.uniboyaca.edu.co/index.php/rs/article/view/373spa
dc.subjectCryptosporidium parvumspa
dc.subjectvacunas sintéticasspa
dc.subjectvacunas de ADNspa
dc.subjectinmunogenicidadspa
dc.subjectantígeno CP15spa
dc.subjectCryptosporidium parvumeng
dc.subjectvaccineseng
dc.subjectsyntheticeng
dc.subjectVaccineseng
dc.subjectDNAeng
dc.subjectsubuniteng
dc.subjectCP15 proteineng
dc.subjectimmunogenicityeng
dc.subjectCryptosporidium parvumeng
dc.subjectvacinas sintéticaseng
dc.subjectvacinas de DNAeng
dc.subjectimunogenicidade da vacinaeng
dc.subjectantígeno CP15eng
dc.titleAvances en el desarrollo de una vacuna efectiva contra Cryptosporidium parvum: una revisión de la literaturaspa
dc.typeArtículo de revistaspa
dc.typeJournal articleeng
dc.identifier.doi10.24267/23897325.373
dc.identifier.eissn2539-2018
dc.identifier.urlhttps://doi.org/10.24267/23897325.373
dc.relation.bitstreamhttps://revistasdigitales.uniboyaca.edu.co/index.php/rs/article/download/373/503
dc.relation.citationeditionNúm. 1 , Año 2020 : Revista Investigación en Salud Universidad de Boyacáspa
dc.relation.citationendpage136
dc.relation.citationissue1spa
dc.relation.citationstartpage118
dc.relation.citationvolume7spa
dc.relation.ispartofjournalRevista Investigación en Salud Universidad de Boyacáspa
dc.relation.referencesStriepen B. Parasitic infections: Time to tackle cryptosporidiosis. Nature. 2013;503(7475):189–91. https://doi.org/10.1038/503189a 2. Korpe PS, Valencia C, Haque R, Mahfuz M, McGrath M, Houpt E, et al. Epidemiology and Risk Factors for Cryptosporidiosis in Children From 8 Low-income Sites: Results From the MAL-ED Study. Clinical Infectious Diseases. 2018;67:1660–9. https://doi.org/10.1093/cid/ciy355 3. Tomazic ML, Maidana J, Dominguez M, Uriarte EL, Galarza R, Garro C, et al. Molecular characterization of Cryptosporidium isolates from calves in Argentina. Vet Parasitol. 2013;198(3–4):382–6. https://doi.org/10.1016/j.vetpar.2013.09.022 4. Chalmers RM, Davies AP, Tyler K. Cryptosporidium. Microbiology. 2019;165(5):500–2. https://doi.org/10.1099/mic.0.000764 5. Abubakar I, Aliyu SH, Arumugam C, Usman NK, Hunter PR. Treatment of cryptosporidiosis in immunocompromised individuals: systematic review and meta-analysis. Br J Clin Pharmacol. 2007;63(4):387–93. https://doi.org/10.1111/j.1365-2125.2007.02873.x 6. Hossain MJ, Saha D, Antonio M, Nasrin D, Blackwelder WC, Ikumapayi UN, et al. Cryptosporidium infection in rural gambian children: Epidemiology and risk factors. PLoS Negl Trop Dis. 2019;13(7):e0007607. https://dx.doi.org/10.1371/journal.pntd.0007607 7. Leitch GJ, He Q. Cryptosporidiosis-an overview. J Biomed Res. 2012;25(1):1–16. https://doi.org/10.1016/S1674-8301(11)60001-8 8. Dumaine JE, Tandel J, Striepen B. Cryptosporidium parvum. Trends in Parasitology. 2019. https://doi.org/10.1016/j.pt.2019.11.003 9. Baldursson S, Karanis P. Waterborne transmission of protozoan parasites: review of worldwide outbreaks - an update 2004-2010. Water Res. 2011;45(20):6603–14. https://doi.org/10.1016/j.watres.2011.10.013 10. Gallas-Lindemann C, Sotiriadou I, Plutzer J, Noack MJ, Mahmoudi MR, Karanis P. Giardia and Cryptosporidium spp. dissemination during wastewater treatment and comparative detection via immunofluorescence assay (IFA), nested polymerase chain reaction (nested PCR) and loop mediated isothermal amplification (LAMP). Acta Trop. 2016;158:43–51. https://doi.org/10.1016/j.actatropica.2016.02.005 11. Lippuner C, Ramakrishnan C, Basso WU, Schmid MW, Okoniewski M, Smith NC, et al. RNA-Seq analysis during the life cycle of Cryptosporidium parvum reveals significant differential gene expression between proliferating stages in the intestine and infectious sporozoites. Int J Parasitol. 2018;48(6):413–22. https://doi.org/10.1016/j.ijpara.2017.10.007 12. Carey CM, Lee H, Trevors JT. Biology, persistence and detection of Cryptosporidium parvum and Cryptosporidium hominis oocyst. Water Res. 2004;38(4):818–62. https://doi.org/10.1016/j.watres.2003.10.012 13. Borowski H, Thompson RCA, Armstrong T, Clode PL. Morphological characterization of Cryptosporidium parvum life-cycle stages in an in vitro model system. Parasitology. 2010;137(1):13–26. https://doi.org/10.1017/S0031182009990837 14. Pulido-Medellín MO, Andrade-Becerra RJ, Rodríguez-Vivas RI, Garcia-Corredor DJ. Prevalencia y posibles factores de riesgo en la excreción de ooquistes de Cryptosporidium spp en bovinos de Boyacá, Colombia. Revista Mexicana de Ciencias Pecuarias. 2015;5(3):357–64 15. Eze UU, Ezeh IO, Nzeakor TA, Attama SC, Ezenduka EV, Onah DN. Prevalence and risk factors associated with Cryptosporidium spp. infection in local breed of dogs in Enugu State, Nigeria. Vet World. 2019;12(5):729–34. https://dx.doi.org/10.14202/vetworld.2019.729-734 16. Hastutiek P, Yuniarti WM, Djaeri M, Lastuti NDR, Suprihati E, Suwanti LT. Prevalence and diversity of gastrointestinal protozoa in Madura cattle at Bangkalan Regency, East Java, Indonesia. Vet World. 2019;12(2):198–204. https://dx.doi.org/10.14202/vetworld.2019.198-204 17. Kotloff KL, Nataro JP, Blackwelder WC, Nasrin D, Farag TH, Panchalingam S, et al. Burden and aetiology of diarrhoeal disease in infants and young children in developing countries (the Global Enteric Multicenter Study, GEMS): a prospective, case-control study. Lancet. 2013;382(9888):209–22. https://doi.org/10.1016/S0140-6736(13)60844-2 18. Rossle NF, Latif B. Cryptosporidiosis as threatening health problem: A review. Asian Pacific Journal of Tropical Biomedicine. 2013;3(11):916–24. https://dx.doi.org/10.1016/S2221-1691(13)60179-3 19. Vanathy K, Parija SC, Mandal J, Hamide A, Krishnamurthy S. Cryptosporidiosis: A mini review. Trop Parasitol. 2017;7(2):72–80. https://doi.org/10.4103/tp.TP_25_17 20. Attili SVS, Gulati AK, Singh VP, Varma DV, Rai M, Sundar S. Diarrhea, CD4 counts and enteric infections in a hospital - based cohort of HIV-infected patients around Varanasi, India. BMC Infect Dis. 2006;6(39):1–8. https://doi.org/10.1186/1471-2334-6-39 21. Dwivedi KK, Prasad G, Saini S, Mahajan S, Lal S, Baveja UK. Enteric opportunistic parasites among HIV infected individuals: associated risk factors and immune status. Jpn J Infect Dis. 2007;60(2–3):76–81 22. Muthusamy D, Rao SS, Ramani S, Monica B, Banerjee I, Abraham OC, et al. Multilocus genotyping of Cryptosporidium sp. isolates from human immunodeficiency virus-infected individuals in South India. J Clin Microbiol. 2006;44(2):632–4. https://doi.org/10.1128/JCM.44.2.632-634.2006 23. Chavez MA, White AC. Novel treatment strategies and drugs in development for cryptosporidiosis. Expert Rev Anti Infect Ther. 2018;16(8):655–61. https://doi.org/10.1080/14787210.2018.1500457 24. Tzipori S, Widmer G. A hundred-year retrospective on cryptosporidiosis. Trends Parasitol. 2008;24(4):184–9. https://dx.doi.org/10.1016/j.pt.2008.01.002 25. Darlan DM, Rozi MF, Andriyani Y, Yulfi H, Saragih RH, Nerdy N. Cryptosporidium Sp. Findings and Its Symptomatology among Immunocompromised Patients. Open Access Maced J Med Sci. 2019;7(10):1567–71. https://doi.org/10.3889/oamjms.2019.329 26. Ehigiator HN, Mcnair N, Mead JR. IL-12 Knockout C57BL/6 Mice are Protected from Re-infection with Cryptosporidium parvum after Challenge. J Eukaryot Microbiol. 2003;50(s1):539–41. https://doi.org/10.1111/j.1550-7408.2003.tb00622.x 27. Yu JR, Park WY. The effect of gamma-irradiation on the viability of Cryptosporidium parvum. J Parasitol. 2003;89(3):639–42. https://doi.org/10.1645/0022-3395(2003)089[0639:TEOIOT]2.0.CO;2 28. Jenkins M, Higgins J, Kniel K, Trout J, Fayer R. Protection of calves against cryptosporiosis by oral inoculation with gamma-irradiated Cryptosporidium parvum oocysts. J Parasitol. 2004;90(5):1178–80. https://doi.org/10.1645/GE-3333RN 29. Wang C, Luo J, Amer S, Guo Y, Hu Y, Lu Y, et al. Multivalent DNA vaccine induces protective immune responses and enhanced resistance against Cryptosporidium parvum infection. Vaccine. 2010;29(2):323–8. https://doi.org/10.1016/j.vaccine.2010.10.034 30. Zheng J, Ren W, Pan Q, Wang Q, elhag IAE, Li J, et al. A recombinant DNA vaccine encoding C. andersoni oocyst wall protein induces immunity against experimental C. parvum infection. Vet Parasitol. 2011;179(1–3):7–13. https://doi.org/10.1016/j.vetpar.2011.02.016 31. Yu Q, Li J, Zhang X, Gong P, Zhang G, Li S, et al. Induction of immune responses in mice by a DNA vaccine encoding Cryptosporidium parvum Cp12 and Cp21 and its effect against homologous oocyst challenge. Vet Parasitol. 2010;172(1–2):1–7. https://doi.org/10.1016/j.vetpar.2010.04.036 32. Liu K, Zai D, Zhang D, Wei Q, Han G, Gao H, et al. Divalent Cp15-23 vaccine enhances immune responses and protection against Cryptosporidium parvum infection. Parasite Immunology. 2010;32(5):335–44. https://doi.org/10.1111/j.1365-3024.2009.01191.x 33. Sagodira S, Iochmann S, Mevelec MN, Dimier-Poisson I, Bout D. Nasal immunization of mice with Cryptosporidium parvum DNA induces systemic and intestinal immune responses. Parasite Immunol. 1999;21(10):507–16. https://doi.org/10.1046/j.1365-3024.1999.00247.x 34. He H, Zhao B, Liu L, Zhou K, Qin X, Zhang Q, et al. The Humoral and Cellular Immune Responses in Mice Induced by DNA Vaccine Expressing the Sporozoite Surface Protein of Cryptosporidium parvum. DNA Cell Biol. 2004;23(5):335–9. https://doi.org/10.1089/104454904323090967 35. Ehigiator HN, Romagnoli P, Priest JW, Secor WE, Mead JR. Induction of murine immune responses by DNA encoding a 23-kDa antigen of Cryptosporidium parvum. Parasitol Res. 2007;101(4):943–50. https://doi.org/10.1007/s00436-007-0565-0 36. Benítez A, Priest JW, Ehigiator HN, McNair N, Mead JR. Evaluation of DNA encoding acidic ribosomal protein P2 of Cryptosporidium parvum as a potential vaccine candidate for cryptosporidiosis. Vaccine. 2011;29(49):9239–45. https://doi.org/10.1016/j.vaccine.2011.09.094 37. Khan KH. DNA vaccines: roles against diseases. GERMS. 2013;3(1):26–35. https://dx.doi.org/10.11599/germs.2013.1034 38. Ludington JG, Ward HD. Systemic and Mucosal Immune Responses to Cryptosporidium—Vaccine Development. Curr Trop Med Rep. 2015;2(3):171–80. https://dx.doi.org/10.1007/s40475-015-0054-y 39. Carleton HA. Pathogenic bacteria as vaccine vectors: teaching old bugs new tricks. Yale J Biol Med. 2010;83(4):217–22. 40. Benítez AJ, McNair N, Mead JR. Oral immunization with attenuated Salmonella enterica serovar Typhimurium encoding Cryptosporidium parvum Cp23 and Cp40 antigens induces a specific immune response in mice. Clin Vaccine Immunol. 2009;16(9):1272–8. https://doi.org/10.1128/CVI.00089-09 41. Manque PA, Tenjo F, Woehlbier U, Lara AM, Serrano MG, Xu P, et al. Identification and Immunological Characterization of Three Potential Vaccinogens against Cryptosporidium Species. Clin Vaccine Immunol. 2011;18(11):1796–802. https://doi.org/10.1128/CVI.05197-11 42. Shirafuji H, Xuan X, Kimata I, Takashima Y, Fukumoto S, Otsuka H, et al. Expression of P23 of Cryptosporidium parvum in Toxoplasma gondii and Evaluation of its Protective Effects. Journal of Parasitology. 2005;91(2):476–9. https://doi.org/10.1645/GE-364R1 43. Stevens TL, Bossie A, Sanders VM, Fernandez-Botran R, Coffman RL, Mosmann TR, et al. Regulation of antibody isotype secretion by subsets of antigen-specific helper T cells. Nature. 1988;334(6179):255–8. https://doi.org/10.1038/334255a0 44. Lemieux M, Sonzogni-Desautels K, Ndao M. Lessons Learned from Protective Immune Responses to Optimize Vaccines against Cryptosporidiosis. Pathogens. 2017;7(1):2. https://dx.doi.org/10.3390/pathogens7010002 45. Geriletu, Xu R, Jia H, Terkawi MA, Xuan X, Zhang H. Immunogenicity of Orally Administrated Recombinant Lactobacillus casei Zhang Expressing Cryptosporidium parvum Surface Adhesion Protein P23 in Mice. Curr Microbiol. 2011;62(5):1573–80. https://doi.org/10.1007/s00284-011-9894-4 46. Kwok LY, Wang L, Zhang J, Guo Z, Zhang H. A pilot study on the effect of Lactobacillus casei Zhang on intestinal microbiota parameters in Chinese subjects of different age. Benef Microbes. 2014;5(3):295–304. https://doi.org/10.3920/BM2013.0047 47. Sobati H, Jasor-Gharebagh H, Honari H. Expression and Purification of gp40/15 Antigen of Cryptosporidium parvum Parasite in Escherichia coli: an Innovative Approach in Vaccine Production. Iranian Red Crescent Medical Journal. 2017;19(4). http://dx.doi.org/10.5812/ircmj.43040 48. Ebrahimzadeh E, Shayan P, Mokhber Dezfouli M, Rahbari S. Recombinant Cryptosporidium parvum p23 as Candidate Vaccine for Cryptosporidiosis. Iranian Journal of Parasitology. 2009;4:1–7. 49. Zhang S, Wang Y, Wu H, Li N, Jiang J, Guo Y, et al. Characterization of a Species-Specific Insulinase-Like Protease in Cryptosporidium parvum. Front Microbiol 2019;10. https://dx.doi.org/10.3389/fmicb.2019.00354 50. Avendaño C, Jenkins M, Méndez-Callejas G, Oviedo J, Guzmán F, Patarroyo MA, et al. Cryptosporidium spp. CP15 and CSL protein-derived synthetic peptides’ immunogenicity and in vitro seroneutralisation capability. Vaccine. 2018;36(45):6703–10. https://doi.org/10.1016/j.vaccine.2018.09.044spa
dc.rights.accessrightsinfo:eu-repo/semantics/openAccessspa
dc.rights.creativecommonsEsta obra está bajo una licencia internacional Creative Commons Atribución-NoComercial 4.0.spa
dc.title.translatedAdvances in the development of an effective vaccine against Cryptosporidium parvum: An review of the literatureeng
dc.type.coarhttp://purl.org/coar/resource_type/c_6501spa
dc.type.coarhttp://purl.org/coar/resource_type/c_dcae04bcspa
dc.type.coarversionhttp://purl.org/coar/version/c_970fb48d4fbd8a85spa
dc.type.contentTextspa
dc.type.driverinfo:eu-repo/semantics/articlespa
dc.type.redcolhttp://purl.org/redcol/resource_type/ARTREVspa
dc.type.versioninfo:eu-repo/semantics/publishedVersionspa
dc.rights.coarhttp://purl.org/coar/access_right/c_abf2spa


Ficheros en el ítem

FicherosTamañoFormatoVer
Revista Investig. Salud Univ. Boyacá-373.pdf1.900Mbapplication/pdfVer/

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem

Revista Investigación en Salud Universidad de Boyacá - 2020
Excepto si se señala otra cosa, la licencia del ítem se describe como Revista Investigación en Salud Universidad de Boyacá - 2020